BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1029939 C[C@H]1[C@H](O)CN1c1nc(cc(c1C#N)C(F)(F)F)N1C[C@H]2[C@H](CC(O)=O)[C@H]2C1 InChI=1S/C18H19F3N4O3/c1-8-14(26)7-25(8)17-10(4-22)13(18(19,20)21)3-15(23-17)24-5-11-9(2-16(27)28)12(11)6-24/h3,8-9,11-12,14,26H,2,5-7H2,1H3,(H,27,28)/t8-,9-,11-,12+,14+/m0/s1 BMYWDILFDVCFJX-GMEDAVPMSA-N 319582 US10174007, Example 1::US10787438, Example 1::US10988463, Example 1::US11634410, Example 1 Ketohexokinase Human 5.50 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319582&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278497 384222870 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029940 C[C@H]1[C@H](O)CN1c1nc(cc(c1C#N)C(F)(F)F)N1C[C@H]2[C@H](CC(O)=O)[C@H]2C1 InChI=1S/C18H19F3N4O3/c1-8-14(26)7-25(8)17-10(4-22)13(18(19,20)21)3-15(23-17)24-5-11-9(2-16(27)28)12(11)6-24/h3,8-9,11-12,14,26H,2,5-7H2,1H3,(H,27,28)/t8-,9-,11-,12+,14+/m0/s1 BMYWDILFDVCFJX-GMEDAVPMSA-N 319582 US10174007, Example 1::US10787438, Example 1::US10988463, Example 1::US11634410, Example 1 Ketohexokinase Human 1.50 US Patent 10.7270/Q2SJ1PRS aid1805504 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319582&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278497 384222870 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029941 C[C@H]1[C@H](O)CN1c1nc(cc(c1C#N)C(F)(F)F)N1C[C@H]2[C@H](CC(O)=O)[C@H]2C1 InChI=1S/C18H19F3N4O3/c1-8-14(26)7-25(8)17-10(4-22)13(18(19,20)21)3-15(23-17)24-5-11-9(2-16(27)28)12(11)6-24/h3,8-9,11-12,14,26H,2,5-7H2,1H3,(H,27,28)/t8-,9-,11-,12+,14+/m0/s1 BMYWDILFDVCFJX-GMEDAVPMSA-N 319582 US10174007, Example 1::US10787438, Example 1::US10988463, Example 1::US11634410, Example 1 Ketohexokinase Human 3.30 US Patent 10.7270/Q2SJ1PRS aid1805505 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319582&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278497 384222870 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029942 C[C@H]1[C@H](O)CN1c1nc(cc(c1C#N)C(F)(F)F)N1C[C@H]2[C@H](CC(O)=O)[C@H]2C1 InChI=1S/C18H19F3N4O3/c1-8-14(26)7-25(8)17-10(4-22)13(18(19,20)21)3-15(23-17)24-5-11-9(2-16(27)28)12(11)6-24/h3,8-9,11-12,14,26H,2,5-7H2,1H3,(H,27,28)/t8-,9-,11-,12+,14+/m0/s1 BMYWDILFDVCFJX-GMEDAVPMSA-N 319582 US10174007, Example 1::US10787438, Example 1::US10988463, Example 1::US11634410, Example 1 Isoform A of Ketohexokinase (Peripheral) Human 7.30 US Patent 10.7270/Q2SJ1PRS aid1805506 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=932&target=Isoform+A+of+Ketohexokinase+%28Peripheral%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319582&enzyme=Isoform+A+of+Ketohexokinase+%28Peripheral%29&column=ki&startPg=0&Increment=50&submit=Search 129278497 384222870 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFVLDDLRRYSVDLRYTVFQTTGSVPIATVIINEASGSRTILYYDRSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 2HQQ,2HW1 Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029943 C[C@H]1[C@H](O)CN1c1nc(N2C[C@H]3[C@H](CC(O)=O)[C@H]3C2)c(Cl)c(c1C#N)C(F)(F)F InChI=1S/C18H18ClF3N4O3/c1-7-12(27)6-26(7)16-9(3-23)14(18(20,21)22)15(19)17(24-16)25-4-10-8(2-13(28)29)11(10)5-25/h7-8,10-12,27H,2,4-6H2,1H3,(H,28,29)/t7-,8-,10-,11+,12+/m0/s1 AZAAHHJOZPEWNT-QATXWYEKSA-N 319583 US10174007, Example 2::US10787438, Example 2::US10988463, Example 2::US11634410, Example 2 Ketohexokinase Human 6.80 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319583&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278639 384222871 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029944 C[C@H]1[C@H](O)CN1c1nc(N2C[C@H]3[C@H](CC(O)=O)[C@H]3C2)c(Cl)c(c1C#N)C(F)(F)F InChI=1S/C18H18ClF3N4O3/c1-7-12(27)6-26(7)16-9(3-23)14(18(20,21)22)15(19)17(24-16)25-4-10-8(2-13(28)29)11(10)5-25/h7-8,10-12,27H,2,4-6H2,1H3,(H,28,29)/t7-,8-,10-,11+,12+/m0/s1 AZAAHHJOZPEWNT-QATXWYEKSA-N 319583 US10174007, Example 2::US10787438, Example 2::US10988463, Example 2::US11634410, Example 2 Ketohexokinase Human 1.50 US Patent 10.7270/Q2SJ1PRS aid1805504 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319583&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278639 384222871 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029945 C[C@H]1[C@H](O)CN1c1nc(N2C[C@H]3[C@H](CC(O)=O)[C@H]3C2)c(Cl)c(c1C#N)C(F)(F)F InChI=1S/C18H18ClF3N4O3/c1-7-12(27)6-26(7)16-9(3-23)14(18(20,21)22)15(19)17(24-16)25-4-10-8(2-13(28)29)11(10)5-25/h7-8,10-12,27H,2,4-6H2,1H3,(H,28,29)/t7-,8-,10-,11+,12+/m0/s1 AZAAHHJOZPEWNT-QATXWYEKSA-N 319583 US10174007, Example 2::US10787438, Example 2::US10988463, Example 2::US11634410, Example 2 Ketohexokinase Human 3.60 US Patent 10.7270/Q2SJ1PRS aid1805505 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319583&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278639 384222871 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029946 COC(=O)C[C@H]1[C@@H]2CN(C[C@H]12)c1cc(nc(n1)N1CC[C@@H]1C)C(F)(F)F InChI=1S/C17H21F3N4O2/c1-9-3-4-24(9)16-21-13(17(18,19)20)6-14(22-16)23-7-11-10(12(11)8-23)5-15(25)26-2/h6,9-12H,3-5,7-8H2,1-2H3/t9-,10-,11-,12+/m0/s1 QVTAJQPFFRLSHX-FIQHERPVSA-N 319584 US10174007, Example 3::US10787438, Example 3::US10988463, Example 3 Ketohexokinase Human 3508 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319584&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129303147 384222872 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029947 C[C@H]1CCN1c1nc(cc(n1)C(F)(F)F)N1C[C@H]2[C@H](CC(O)=O)[C@H]2C1 InChI=1S/C16H19F3N4O2/c1-8-2-3-23(8)15-20-12(16(17,18)19)5-13(21-15)22-6-10-9(4-14(24)25)11(10)7-22/h5,8-11H,2-4,6-7H2,1H3,(H,24,25)/t8-,9-,10-,11+/m0/s1 MDUYWDNWFXSMJJ-XWLWVQCSSA-N 319585 US10174007, Example 4::US10787438, Example 4::US10988463, Example 4::US11634410, Example 4 Ketohexokinase Human 14.2 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319585 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319585&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278694 384222873 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029948 C[C@H]1CCN1c1nc(cc(n1)C(F)(F)F)N1C[C@H]2[C@H](CC(O)=O)[C@H]2C1 InChI=1S/C16H19F3N4O2/c1-8-2-3-23(8)15-20-12(16(17,18)19)5-13(21-15)22-6-10-9(4-14(24)25)11(10)7-22/h5,8-11H,2-4,6-7H2,1H3,(H,24,25)/t8-,9-,10-,11+/m0/s1 MDUYWDNWFXSMJJ-XWLWVQCSSA-N 319585 US10174007, Example 4::US10787438, Example 4::US10988463, Example 4::US11634410, Example 4 Ketohexokinase Human 8.40 US Patent 10.7270/Q2SJ1PRS aid1805504 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319585 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319585&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278694 384222873 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029949 C[C@H]1CCN1c1nc(cc(n1)C(F)(F)F)N1C[C@H]2[C@H](CC(O)=O)[C@H]2C1 InChI=1S/C16H19F3N4O2/c1-8-2-3-23(8)15-20-12(16(17,18)19)5-13(21-15)22-6-10-9(4-14(24)25)11(10)7-22/h5,8-11H,2-4,6-7H2,1H3,(H,24,25)/t8-,9-,10-,11+/m0/s1 MDUYWDNWFXSMJJ-XWLWVQCSSA-N 319585 US10174007, Example 4::US10787438, Example 4::US10988463, Example 4::US11634410, Example 4 Ketohexokinase Human 37.3 US Patent 10.7270/Q2SJ1PRS aid1805505 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319585 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319585&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278694 384222873 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029950 C[C@H]1CCN1c1nc(cc(n1)C(F)(F)F)N1C[C@H]2[C@H](CC(O)=O)[C@H]2C1 InChI=1S/C16H19F3N4O2/c1-8-2-3-23(8)15-20-12(16(17,18)19)5-13(21-15)22-6-10-9(4-14(24)25)11(10)7-22/h5,8-11H,2-4,6-7H2,1H3,(H,24,25)/t8-,9-,10-,11+/m0/s1 MDUYWDNWFXSMJJ-XWLWVQCSSA-N 319585 US10174007, Example 4::US10787438, Example 4::US10988463, Example 4::US11634410, Example 4 Isoform A of Ketohexokinase (Peripheral) Human 66.0 US Patent 10.7270/Q2SJ1PRS aid1805506 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319585 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=932&target=Isoform+A+of+Ketohexokinase+%28Peripheral%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319585&enzyme=Isoform+A+of+Ketohexokinase+%28Peripheral%29&column=ki&startPg=0&Increment=50&submit=Search 129278694 384222873 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFVLDDLRRYSVDLRYTVFQTTGSVPIATVIINEASGSRTILYYDRSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 2HQQ,2HW1 Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029951 C[C@H]1[C@H](O)CN1c1nc(cc(n1)C(F)(F)F)N1C[C@H]2[C@H](CC(O)=O)[C@H]2C1 InChI=1S/C16H19F3N4O3/c1-7-11(24)6-23(7)15-20-12(16(17,18)19)3-13(21-15)22-4-9-8(2-14(25)26)10(9)5-22/h3,7-11,24H,2,4-6H2,1H3,(H,25,26)/t7-,8-,9-,10+,11+/m0/s1 BCRDBPWNFULPMK-LADJIXMOSA-N 319586 US10174007, Example 5::US10787438, Example 5::US10988463, Example 5::US11634410, Example 5 Ketohexokinase Human 24.7 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319586 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319586&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278758 384222874 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029952 C[C@H]1[C@H](O)CN1c1nc(cc(n1)C(F)(F)F)N1C[C@H]2[C@H](CC(O)=O)[C@H]2C1 InChI=1S/C16H19F3N4O3/c1-7-11(24)6-23(7)15-20-12(16(17,18)19)3-13(21-15)22-4-9-8(2-14(25)26)10(9)5-22/h3,7-11,24H,2,4-6H2,1H3,(H,25,26)/t7-,8-,9-,10+,11+/m0/s1 BCRDBPWNFULPMK-LADJIXMOSA-N 319586 US10174007, Example 5::US10787438, Example 5::US10988463, Example 5::US11634410, Example 5 Ketohexokinase Human 13.6 US Patent 10.7270/Q2SJ1PRS aid1805504 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319586 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319586&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278758 384222874 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029953 C[C@H]1[C@H](O)CN1c1nc(cc(n1)C(F)(F)F)N1C[C@H]2[C@H](CC(O)=O)[C@H]2C1 InChI=1S/C16H19F3N4O3/c1-7-11(24)6-23(7)15-20-12(16(17,18)19)3-13(21-15)22-4-9-8(2-14(25)26)10(9)5-22/h3,7-11,24H,2,4-6H2,1H3,(H,25,26)/t7-,8-,9-,10+,11+/m0/s1 BCRDBPWNFULPMK-LADJIXMOSA-N 319586 US10174007, Example 5::US10787438, Example 5::US10988463, Example 5::US11634410, Example 5 Ketohexokinase Human 58.8 US Patent 10.7270/Q2SJ1PRS aid1805505 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319586 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319586&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278758 384222874 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029954 C[C@H]1[C@H](O)CN1c1nc(cc(n1)C(F)(F)F)N1C[C@H]2[C@H](CC(O)=O)[C@H]2C1 InChI=1S/C16H19F3N4O3/c1-7-11(24)6-23(7)15-20-12(16(17,18)19)3-13(21-15)22-4-9-8(2-14(25)26)10(9)5-22/h3,7-11,24H,2,4-6H2,1H3,(H,25,26)/t7-,8-,9-,10+,11+/m0/s1 BCRDBPWNFULPMK-LADJIXMOSA-N 319586 US10174007, Example 5::US10787438, Example 5::US10988463, Example 5::US11634410, Example 5 Isoform A of Ketohexokinase (Peripheral) Human 95.5 US Patent 10.7270/Q2SJ1PRS aid1805506 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319586 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=932&target=Isoform+A+of+Ketohexokinase+%28Peripheral%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319586&enzyme=Isoform+A+of+Ketohexokinase+%28Peripheral%29&column=ki&startPg=0&Increment=50&submit=Search 129278758 384222874 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFVLDDLRRYSVDLRYTVFQTTGSVPIATVIINEASGSRTILYYDRSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 2HQQ,2HW1 Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029955 OC(=O)C[C@H]1[C@@H]2CN(C[C@H]12)c1cc(nc(n1)C1CCC1)C(F)(F)F InChI=1S/C16H18F3N3O2/c17-16(18,19)12-5-13(21-15(20-12)8-2-1-3-8)22-6-10-9(4-14(23)24)11(10)7-22/h5,8-11H,1-4,6-7H2,(H,23,24)/t9-,10-,11+ WWIQGKOATHSZGR-RTCCRHLQSA-N 319587 US10174007, Example 6::US10988463, Example 6::US11634410, Example 6 Ketohexokinase Human 170 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319587&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278511 384222875 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029956 C[C@H]1[C@H](O)CN1c1nc(N2C[C@H]3[C@H](CC(O)=O)[C@H]3C2)c(C2CC2)c(n1)C(F)(F)F InChI=1S/C19H23F3N4O3/c1-8-13(27)7-26(8)18-23-16(19(20,21)22)15(9-2-3-9)17(24-18)25-5-11-10(4-14(28)29)12(11)6-25/h8-13,27H,2-7H2,1H3,(H,28,29)/t8-,10-,11-,12+,13+/m0/s1 OLZMLWDRLUHLHZ-KHAFSYESSA-N 319588 US10174007, Example 7::US10787438, Example 7::US10988463, Example 7::US11634410, Example 7 Ketohexokinase Human 111 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319588 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319588&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278774 384222876 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029957 CCc1c(nc(nc1C(F)(F)F)N1C[C@@H](O)[C@@H]1C)N1C[C@H]2[C@H](CC(O)=O)[C@H]2C1 InChI=1S/C18H23F3N4O3/c1-3-9-15(18(19,20)21)22-17(25-7-13(26)8(25)2)23-16(9)24-5-11-10(4-14(27)28)12(11)6-24/h8,10-13,26H,3-7H2,1-2H3,(H,27,28)/t8-,10-,11-,12+,13+/m0/s1 SOSUXIVAGRPMCG-KHAFSYESSA-N 319589 US10174007, Example 8::US10787438, Example 8::US10988463, Example 8::US11634410, Example 8 Ketohexokinase Human 53.8 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319589 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319589&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278500 384222877 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029958 C[C@@H]1N(C[C@@]1(C)O)c1nc(cc(n1)C(F)(F)F)N1C[C@H]2[C@H](CS(C)(=O)=O)[C@H]2C1 InChI=1S/C17H23F3N4O3S/c1-9-16(2,25)8-24(9)15-21-13(17(18,19)20)4-14(22-15)23-5-10-11(6-23)12(10)7-28(3,26)27/h4,9-12,25H,5-8H2,1-3H3/t9-,10-,11+,12+,16+/m0/s1 VWXCOTRCSDGKEY-GBNBPPIOSA-N 319590 US10174007, Example 9::US10787438, Example 9::US10988463, Example 9::US11634410, Example 9 Ketohexokinase Human 14361 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319590 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319590&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278728 384222878 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029959 C[C@H]1CCN1c1nc(cc(n1)C(F)(F)F)N1C[C@H]2[C@H](CC(=O)NS(C)(=O)=O)[C@H]2C1 InChI=1S/C17H22F3N5O3S/c1-9-3-4-25(9)16-21-13(17(18,19)20)6-14(22-16)24-7-11-10(12(11)8-24)5-15(26)23-29(2,27)28/h6,9-12H,3-5,7-8H2,1-2H3,(H,23,26)/t9-,10-,11-,12+/m0/s1 YIJQJKBSWSLTEE-FIQHERPVSA-N 319591 US10174007, Example 10::US10787438, Example 10::US10988463, Example 10::US11634410, Example 10 Ketohexokinase Human 682 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319591 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319591&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278773 384222879 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029960 C[C@H]1CCN1c1nc(cc(n1)C(F)(F)F)N1C[C@H]2[C@H](Cc3nnn[nH]3)[C@H]2C1 319592 US10174007, Example 11::US10787438, Example 11::US10988463, Example 11::US11634410, Example 11 Ketohexokinase Human 866 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319592 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319592&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278876 384222880 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029961 C[C@H]1[C@H](O)CN1c1nc(N2C[C@H]3[C@H](CC(O)=O)[C@H]3C2)c(Cl)c(n1)C(C)(F)F InChI=1S/C17H21ClF2N4O3/c1-7-11(25)6-24(7)16-21-14(17(2,19)20)13(18)15(22-16)23-4-9-8(3-12(26)27)10(9)5-23/h7-11,25H,3-6H2,1-2H3,(H,26,27)/t7-,8-,9-,10+,11+/m0/s1 NGEBOCPTYJZMAV-LADJIXMOSA-N 494878 US10988463, Example 12::US11634410, Example 18 Ketohexokinase Human 289 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494878&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 134235910 447113337 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029962 COc1c(nc(nc1C(F)(F)F)N1C[C@@H](O)[C@@H]1C)N1C[C@H]2[C@H](CC(O)=O)[C@H]2C1 InChI=1S/C17H21F3N4O4/c1-7-11(25)6-24(7)16-21-14(17(18,19)20)13(28-2)15(22-16)23-4-9-8(3-12(26)27)10(9)5-23/h7-11,25H,3-6H2,1-2H3,(H,26,27)/t7-,8-,9-,10+,11+/m0/s1 CDDUZNXDZXURAV-LADJIXMOSA-N 319598 US10174007, Example 13::US10787438, Example 13::US10988463, Example 13::US11634410, Example 13 Ketohexokinase Human 33.9 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=319598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=319598&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 129278495 384222886 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029963 C[C@H]1[C@H](O)CN1c1nc(c(C)c(n1)C12CNCC1C2CC(O)=O)C(F)(F)F InChI=1S/C17H21F3N4O3/c1-7-13(16-6-21-4-10(16)9(16)3-12(26)27)22-15(23-14(7)17(18,19)20)24-5-11(25)8(24)2/h8-11,21,25H,3-6H2,1-2H3,(H,26,27)/t8-,9?,10?,11+,16?/m0/s1 FIDCOOGXAYYGDL-WRCLSMMLSA-N 494880 US10988463, Example 24::[(1R,5S,6R)-3-{2-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]-5-methyl-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 9.70 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494880&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 156905951 447113339 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029964 C[C@H]1[C@H](O)CN1c1nc(c(C)c(n1)C12CNCC1C2CC(O)=O)C(F)(F)F InChI=1S/C17H21F3N4O3/c1-7-13(16-6-21-4-10(16)9(16)3-12(26)27)22-15(23-14(7)17(18,19)20)24-5-11(25)8(24)2/h8-11,21,25H,3-6H2,1-2H3,(H,26,27)/t8-,9?,10?,11+,16?/m0/s1 FIDCOOGXAYYGDL-WRCLSMMLSA-N 494880 US10988463, Example 24::[(1R,5S,6R)-3-{2-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]-5-methyl-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 3.30 US Patent 10.7270/Q2SJ1PRS aid1805504 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494880&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 156905951 447113339 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029965 C[C@H]1[C@H](O)CN1c1nc(c(C)c(n1)C12CNCC1C2CC(O)=O)C(F)(F)F InChI=1S/C17H21F3N4O3/c1-7-13(16-6-21-4-10(16)9(16)3-12(26)27)22-15(23-14(7)17(18,19)20)24-5-11(25)8(24)2/h8-11,21,25H,3-6H2,1-2H3,(H,26,27)/t8-,9?,10?,11+,16?/m0/s1 FIDCOOGXAYYGDL-WRCLSMMLSA-N 494880 US10988463, Example 24::[(1R,5S,6R)-3-{2-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]-5-methyl-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 11.0 US Patent 10.7270/Q2SJ1PRS aid1805505 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494880&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 156905951 447113339 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029966 C[C@H]1[C@H](O)CN1c1nc(c(C)c(n1)C12CNCC1C2CC(O)=O)C(F)(F)F InChI=1S/C17H21F3N4O3/c1-7-13(16-6-21-4-10(16)9(16)3-12(26)27)22-15(23-14(7)17(18,19)20)24-5-11(25)8(24)2/h8-11,21,25H,3-6H2,1-2H3,(H,26,27)/t8-,9?,10?,11+,16?/m0/s1 FIDCOOGXAYYGDL-WRCLSMMLSA-N 494880 US10988463, Example 24::[(1R,5S,6R)-3-{2-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]-5-methyl-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Isoform A of Ketohexokinase (Peripheral) Human 12.1 US Patent 10.7270/Q2SJ1PRS aid1805506 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=932&target=Isoform+A+of+Ketohexokinase+%28Peripheral%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494880&enzyme=Isoform+A+of+Ketohexokinase+%28Peripheral%29&column=ki&startPg=0&Increment=50&submit=Search 156905951 447113339 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFVLDDLRRYSVDLRYTVFQTTGSVPIATVIINEASGSRTILYYDRSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 2HQQ,2HW1 Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029967 C[C@H]1CCN1c1nc(C(F)F)c(Cl)c(n1)N1CC2C(CC(O)=O)C2C1 InChI=1S/C16H19ClF2N4O2/c1-7-2-3-23(7)16-20-13(14(18)19)12(17)15(21-16)22-5-9-8(4-11(24)25)10(9)6-22/h7-10,14H,2-6H2,1H3,(H,24,25)/t7-,8?,9?,10?/m0/s1 AFUXAZPXNHXKOK-KJTVYLTBSA-N 494881 US10988463, Example 40::[(1R,5S,6R)-3-{5-chloro-6-(difluoromethyl)-2-[(2S)-2-methylazetidin-1-yl]pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 11.1 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494881&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773157 447113340 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029968 C[C@H]1CCN1c1nc(C(F)F)c(Cl)c(n1)N1CC2C(CC(O)=O)C2C1 InChI=1S/C16H19ClF2N4O2/c1-7-2-3-23(7)16-20-13(14(18)19)12(17)15(21-16)22-5-9-8(4-11(24)25)10(9)6-22/h7-10,14H,2-6H2,1H3,(H,24,25)/t7-,8?,9?,10?/m0/s1 AFUXAZPXNHXKOK-KJTVYLTBSA-N 494881 US10988463, Example 40::[(1R,5S,6R)-3-{5-chloro-6-(difluoromethyl)-2-[(2S)-2-methylazetidin-1-yl]pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 3.70 US Patent 10.7270/Q2SJ1PRS aid1805504 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494881&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773157 447113340 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029969 C[C@H]1CCN1c1nc(N2CC3C(CC(O)=O)C3C2)c(C)c(n1)C(F)(F)F InChI=1S/C17H21F3N4O2/c1-8-3-4-24(8)16-21-14(17(18,19)20)9(2)15(22-16)23-6-11-10(5-13(25)26)12(11)7-23/h8,10-12H,3-7H2,1-2H3,(H,25,26)/t8-,10?,11?,12?/m0/s1 CIHZZUDENLLBPT-QHMVTXTQSA-N 494882 US10988463, Example 42::[(1R,5S,6R)-3-{5-methyl-2-[(2S)-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 8.80 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494882&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773158 447113341 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029970 C[C@H]1CCN1c1nc(N2CC3C(CC(O)=O)C3C2)c(C)c(n1)C(F)(F)F InChI=1S/C17H21F3N4O2/c1-8-3-4-24(8)16-21-14(17(18,19)20)9(2)15(22-16)23-6-11-10(5-13(25)26)12(11)7-23/h8,10-12H,3-7H2,1-2H3,(H,25,26)/t8-,10?,11?,12?/m0/s1 CIHZZUDENLLBPT-QHMVTXTQSA-N 494882 US10988463, Example 42::[(1R,5S,6R)-3-{5-methyl-2-[(2S)-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 2.40 US Patent 10.7270/Q2SJ1PRS aid1805504 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494882&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773158 447113341 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029971 C[C@H]1CCN1c1nc(C(F)F)c(C)c(n1)N1CC2C(CC(O)=O)C2C1 InChI=1S/C17H22F2N4O2/c1-8-3-4-23(8)17-20-14(15(18)19)9(2)16(21-17)22-6-11-10(5-13(24)25)12(11)7-22/h8,10-12,15H,3-7H2,1-2H3,(H,24,25)/t8-,10?,11?,12?/m0/s1 LVJUPDGITGVFAM-QHMVTXTQSA-N 494883 US10988463, Example 43::[(1R,5S,6R)-3-{6-(difluoromethyl)-5-methyl-2-[(2S)-2-methylazetidin-1-yl]pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 17.8 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494883&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773188 447113342 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029972 C[C@H]1CCN1c1nc(C(F)F)c(C)c(n1)N1CC2C(CC(O)=O)C2C1 InChI=1S/C17H22F2N4O2/c1-8-3-4-23(8)17-20-14(15(18)19)9(2)16(21-17)22-6-11-10(5-13(24)25)12(11)7-22/h8,10-12,15H,3-7H2,1-2H3,(H,24,25)/t8-,10?,11?,12?/m0/s1 LVJUPDGITGVFAM-QHMVTXTQSA-N 494883 US10988463, Example 43::[(1R,5S,6R)-3-{6-(difluoromethyl)-5-methyl-2-[(2S)-2-methylazetidin-1-yl]pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 8.00 US Patent 10.7270/Q2SJ1PRS aid1805504 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494883&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773188 447113342 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029973 C[C@H]1[C@H](O)CN1c1nc(N2CC3C(CC(O)=O)C3C2)c(F)c(c1C#N)C(C)(F)F InChI=1S/C19H21F3N4O3/c1-8-13(27)7-26(8)17-10(4-23)15(19(2,21)22)16(20)18(24-17)25-5-11-9(3-14(28)29)12(11)6-25/h8-9,11-13,27H,3,5-7H2,1-2H3,(H,28,29)/t8-,9?,11?,12?,13+/m0/s1 MAIIPHAMPGZLMT-VALCMSPSSA-N 494884 US10988463, Example 50::[(1R,5S,6R)-3-{5-cyano-4-(1,1-difluoroethyl)-3-fluoro-6-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]pyridin-2-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 4.40 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494884&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 140794830 447113343 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029974 C[C@H]1[C@H](O)CN1c1nc(N2CC3C(CC(O)=O)C3C2)c(F)c(c1C#N)C(C)(F)F InChI=1S/C19H21F3N4O3/c1-8-13(27)7-26(8)17-10(4-23)15(19(2,21)22)16(20)18(24-17)25-5-11-9(3-14(28)29)12(11)6-25/h8-9,11-13,27H,3,5-7H2,1-2H3,(H,28,29)/t8-,9?,11?,12?,13+/m0/s1 MAIIPHAMPGZLMT-VALCMSPSSA-N 494884 US10988463, Example 50::[(1R,5S,6R)-3-{5-cyano-4-(1,1-difluoroethyl)-3-fluoro-6-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]pyridin-2-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 1.50 US Patent 10.7270/Q2SJ1PRS aid1805504 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494884&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 140794830 447113343 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029975 C[C@H]1[C@H](O)CN1c1nc(N2CC3C(CC(O)=O)C3C2)c(F)c(c1C#N)C(C)(F)F InChI=1S/C19H21F3N4O3/c1-8-13(27)7-26(8)17-10(4-23)15(19(2,21)22)16(20)18(24-17)25-5-11-9(3-14(28)29)12(11)6-25/h8-9,11-13,27H,3,5-7H2,1-2H3,(H,28,29)/t8-,9?,11?,12?,13+/m0/s1 MAIIPHAMPGZLMT-VALCMSPSSA-N 494884 US10988463, Example 50::[(1R,5S,6R)-3-{5-cyano-4-(1,1-difluoroethyl)-3-fluoro-6-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]pyridin-2-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 2.60 US Patent 10.7270/Q2SJ1PRS aid1805505 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494884&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 140794830 447113343 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029976 C[C@H]1[C@H](O)CN1c1nc(cc(n1)N1CC2C(CC(O)=O)C2C1)C(F)F InChI=1S/C16H20F2N4O3/c1-7-12(23)6-22(7)16-19-11(15(17)18)3-13(20-16)21-4-9-8(2-14(24)25)10(9)5-21/h3,7-10,12,15,23H,2,4-6H2,1H3,(H,24,25)/t7-,8?,9?,10?,12+/m0/s1 ZLNJGZMQIVRIGX-LPKSZHRFSA-N 494885 US10988463, Example 14::[(1R,5S,6R)-3-{6-(difluoromethyl)-2-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 152 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494885&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773165 447113344 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029977 C[C@H]1[C@H](O)CN1c1nc(C(F)F)c(Cl)c(n1)C12CNCC1C2CC(O)=O InChI=1S/C16H19ClF2N4O3/c1-6-9(24)4-23(6)15-21-12(14(18)19)11(17)13(22-15)16-5-20-3-8(16)7(16)2-10(25)26/h6-9,14,20,24H,2-5H2,1H3,(H,25,26)/t6-,7?,8?,9+,16?/m0/s1 ZWUTXJHRUWVKFS-XYWYPKOESA-N 494886 US10988463, Example 15::[(1R,5S,6R)-3-{5-chloro-6-(difluoromethyl)-2-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 19.1 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494886&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 156905952 447113345 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029978 C[C@H]1[C@H](O)CN1c1nc(N2CC3C(CC(O)=O)C3C2)c(Cl)c(n1)C(F)(F)F InChI=1S/C16H18ClF3N4O3/c1-6-10(25)5-24(6)15-21-13(16(18,19)20)12(17)14(22-15)23-3-8-7(2-11(26)27)9(8)4-23/h6-10,25H,2-5H2,1H3,(H,26,27)/t6-,7?,8?,9?,10+/m0/s1 FYIIVGGOOVQJJT-HRLXQSQDSA-N 494887 US10988463, Example 16::[(1R,5S,6R)-3-{5-chloro-2-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 6.40 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494887&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773195 447113346 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029979 C[C@H]1[C@H](O)CN1c1nc(cc(n1)C(C)(F)F)N1CC2C(CC(O)=O)C2C1 InChI=1S/C17H22F2N4O3/c1-8-12(24)7-23(8)16-20-13(17(2,18)19)4-14(21-16)22-5-10-9(3-15(25)26)11(10)6-22/h4,8-12,24H,3,5-7H2,1-2H3,(H,25,26)/t8-,9?,10?,11?,12+/m0/s1 GEOJDZYCBIRUPG-RQIAXRPDSA-N 494888 US10988463, Example 17::[(1R,5S,6R)-3-{6-(1,1-difluoroethyl)-2-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 131 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494888&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773183 447113347 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029980 C[C@H]1[C@H](O)CN1c1nc(N2CC3C(CC(O)=O)C3C2)c(Cl)c(n1)C(C)(F)F InChI=1S/C17H21ClF2N4O3/c1-7-11(25)6-24(7)16-21-14(17(2,19)20)13(18)15(22-16)23-4-9-8(3-12(26)27)10(9)5-23/h7-11,25H,3-6H2,1-2H3,(H,26,27)/t7-,8?,9?,10?,11+/m0/s1 NGEBOCPTYJZMAV-IGDWCOGCSA-N 494889 US10988463, Example 18::[(1R,5S,6R)-3-{5-chloro-6-(1,1-difluoroethyl)-2-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 16.7 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494889&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773182 447113348 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029981 C[C@H]1CCN1c1nc(cc(C(F)F)c1C#N)N1CC2C(CC(O)=O)C2C1 InChI=1S/C18H20F2N4O2/c1-9-2-3-24(9)18-12(6-21)11(17(19)20)4-15(22-18)23-7-13-10(5-16(25)26)14(13)8-23/h4,9-10,13-14,17H,2-3,5,7-8H2,1H3,(H,25,26)/t9-,10?,13?,14?/m0/s1 KTDXNMLAVSCAQW-CBWZGZIKSA-N 494890 US10988463, Example 19::[(1R,5S,6R)-3-{5-cyano-4-(difluoromethyl)-6-[(2S)-2-methylazetidin-1-yl]pyridin-2-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 7.20 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494890&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773178 447113349 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029982 C[C@H]1[C@H](O)CN1c1nc(C(F)F)c(C)c(n1)N1CC2C(CC(O)=O)C2C1 InChI=1S/C17H22F2N4O3/c1-7-14(15(18)19)20-17(23-6-12(24)8(23)2)21-16(7)22-4-10-9(3-13(25)26)11(10)5-22/h8-12,15,24H,3-6H2,1-2H3,(H,25,26)/t8-,9?,10?,11?,12+/m0/s1 IUBPPTURUZLIKL-RQIAXRPDSA-N 494891 US10988463, Example 20::[(1R,5S,6R)-3-{6-(difluoromethyl)-2-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]-5-methylpyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 33.4 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494891&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773175 447113350 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029983 C[C@@H]1N(C[C@@]1(C)O)c1nc(N2CC3C(CC(O)=O)C3C2)c(Cl)c(C(F)F)c1C#N InChI=1S/C19H21ClF2N4O3/c1-8-19(2,29)7-26(8)17-10(4-23)14(16(21)22)15(20)18(24-17)25-5-11-9(3-13(27)28)12(11)6-25/h8-9,11-12,16,29H,3,5-7H2,1-2H3,(H,27,28)/t8-,9?,11?,12?,19+/m0/s1 NQEJWPRACJNXNT-ZONUPTIBSA-N 494892 US10988463, Example 21::[(1R,5S,6R)-3-{3-chloro-5-cyano-4-(difluoromethyl)-6-[(2S,3R)-3-hydroxy-2,3-dimethylazetidin-1-yl]pyridin-2-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 8.70 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494892&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773172 447113351 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029984 C[C@@H]1N(C[C@@]1(C)O)c1nc(cc(n1)C(F)(F)F)N1CC2C(CC(O)=O)C2C1 InChI=1S/C17H21F3N4O3/c1-8-16(2,27)7-24(8)15-21-12(17(18,19)20)4-13(22-15)23-5-10-9(3-14(25)26)11(10)6-23/h4,8-11,27H,3,5-7H2,1-2H3,(H,25,26)/t8-,9?,10?,11?,16+/m0/s1 BPBQNXPVNNZHBM-PDGIKCBQSA-N 494893 US10988463, Example 22::[(1R,5S,6R)-3-{2-[(2S,3R)-3-hydroxy-2,3-dimethylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 703 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494893 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494893&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773185 447113352 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029985 C[C@H]1C[C@H](O)CN1c1nc(cc(c1C#N)C(F)(F)F)C12CNCC1C2CC(O)=O InChI=1S/C19H21F3N4O3/c1-9-2-10(27)7-26(9)17-11(5-23)12(19(20,21)22)3-15(25-17)18-8-24-6-14(18)13(18)4-16(28)29/h3,9-10,13-14,24,27H,2,4,6-8H2,1H3,(H,28,29)/t9-,10-,13?,14?,18?/m0/s1 YRVKXDCIPDDRTN-KENGHFEDSA-N 494894 US10988463, Example 23::[(1R,5S,6R)-3-{5-cyano-6-[(2S,4S)-4-hydroxy-2-methylpyrrolidin-1-yl]-4-(trifluoromethyl)pyridin-2-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 11.6 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494894&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 156905953 447113353 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029986 C[C@H]1[C@H](O)CN1c1nc(c(C)c(n1)C12CNCC1C2CC(O)=O)C(F)(F)F InChI=1S/C17H21F3N4O3/c1-7-13(16-6-21-4-10(16)9(16)3-12(26)27)22-15(23-14(7)17(18,19)20)24-5-11(25)8(24)2/h8-11,21,25H,3-6H2,1-2H3,(H,26,27)/t8-,9?,10?,11+,16?/m0/s1 FIDCOOGXAYYGDL-WRCLSMMLSA-N 494880 US10988463, Example 24::[(1R,5S,6R)-3-{2-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]-5-methyl-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 9.70 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494880&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 156905951 447113339 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029987 C[C@@H]1N(C[C@@]1(C)O)c1nc(C(F)F)c(C)c(n1)N1CC2C(CC(O)=O)C2C1 InChI=1S/C18H24F2N4O3/c1-8-14(15(19)20)21-17(24-7-18(3,27)9(24)2)22-16(8)23-5-11-10(4-13(25)26)12(11)6-23/h9-12,15,27H,4-7H2,1-3H3,(H,25,26)/t9-,10?,11?,12?,18+/m0/s1 SXPWTHOKJYCRJC-KGIDAQRJSA-N 494895 US10988463, Example 25::[(1R,5S,6R)-3-{6-(difluoromethyl)-2-[(2S,3R)-3-hydroxy-2,3-dimethylazetidin-1-yl]-5-methylpyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 259 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494895&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773190 447113354 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029988 C[C@@H]1N(C[C@@]1(C)O)c1nc(N2CC3C(CC(O)=O)C3C2)c(C)c(n1)C(F)(F)F InChI=1S/C18H23F3N4O3/c1-8-14(18(19,20)21)22-16(25-7-17(3,28)9(25)2)23-15(8)24-5-11-10(4-13(26)27)12(11)6-24/h9-12,28H,4-7H2,1-3H3,(H,26,27)/t9-,10?,11?,12?,17+/m0/s1 HIYIBRUFHDVQJB-RFTWNOHDSA-N 494896 US10988463, Example 26::[(1R,5S,6R)-3-{2-[(2S,3R)-3-hydroxy-2,3-dimethylazetidin-1-yl]-5-methyl-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 63.6 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494896&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773194 447113355 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029989 C[C@H]1[C@H](O)CN1c1cc(cc(n1)C(F)(F)F)N1CC2C(CC(O)=O)C2C1 InChI=1S/C17H20F3N3O3/c1-8-13(24)7-23(8)15-3-9(2-14(21-15)17(18,19)20)22-5-11-10(4-16(25)26)12(11)6-22/h2-3,8,10-13,24H,4-7H2,1H3,(H,25,26)/t8-,10?,11?,12?,13+/m0/s1 FULVWTQOPJVQFV-HCBLXQITSA-N 494897 US10988463, Example 27::[(1R,5S,6R)-3-{2-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyridin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 109 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494897&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773181 447113356 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029990 C[C@H]1CCCN1c1nc(cc(n1)C(F)(F)F)N1CC2C(CC(O)=O)C2C1 InChI=1S/C17H21F3N4O2/c1-9-3-2-4-24(9)16-21-13(17(18,19)20)6-14(22-16)23-7-11-10(5-15(25)26)12(11)8-23/h6,9-12H,2-5,7-8H2,1H3,(H,25,26)/t9-,10?,11?,12?/m0/s1 YBNWHTJAMPKWFK-ZLMIFYAYSA-N 494898 US10988463, Example 28::[(1R,5S,6R)-3-{2-[(2S)-2-methylpyrrolidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 120 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494898 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494898&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773170 447113357 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029991 COc1c(nc(nc1N1CC2C(CC(O)=O)C2C1)N1C[C@@H](O)[C@@H]1C)C(F)F InChI=1S/C17H22F2N4O4/c1-7-11(24)6-23(7)17-20-13(15(18)19)14(27-2)16(21-17)22-4-9-8(3-12(25)26)10(9)5-22/h7-11,15,24H,3-6H2,1-2H3,(H,25,26)/t7-,8?,9?,10?,11+/m0/s1 VFWAREMNMRSZLX-IGDWCOGCSA-N 494899 US10988463, Example 29::[(1R,5S,6R)-3-{6-(difluoromethyl)-2-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]-5-methoxypyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 265 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494899&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773159 447113358 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029992 C[C@H]1[C@H](O)CN1c1nc(nc(n1)C(F)(F)F)N1CC2C(CC(O)=O)C2C1 InChI=1S/C15H18F3N5O3/c1-6-10(24)5-23(6)14-20-12(15(16,17)18)19-13(21-14)22-3-8-7(2-11(25)26)9(8)4-22/h6-10,24H,2-5H2,1H3,(H,25,26)/t6-,7?,8?,9?,10+/m0/s1 XWMDIGUPVOJLNE-HRLXQSQDSA-N 494900 US10988463, Example 30::[(1R,5S,6R)-3-{4-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]-6-(trifluoromethyl)-1,3,5-triazin-2-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 509 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494900&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773167 447113359 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029993 OC(=O)CC1C2CN(CC12)c1cc(c(C#N)c(n1)C1CCC1)C(F)(F)F InChI=1S/C18H18F3N3O2/c19-18(20,21)14-5-15(23-17(11(14)6-22)9-2-1-3-9)24-7-12-10(4-16(25)26)13(12)8-24/h5,9-10,12-13H,1-4,7-8H2,(H,25,26) DNIHBEKIZTYAQR-UHFFFAOYSA-N 494901 US10988463, Example 31::{(1R,5S,6s)-3-[5-cyano-6-cyclobutyl-4-(trifluoromethyl)pyridin-2-yl]-3-azabicyclo[3.1.0]hex-6-yl}acetic acid Ketohexokinase Human 30.0 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494901&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773184 447113360 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029994 C[C@H]1[C@H](O)CN1c1cc(nc(n1)C(F)(F)F)N1CC2C(CC(O)=O)C2C1 InChI=1S/C16H19F3N4O3/c1-7-11(24)6-23(7)13-3-12(20-15(21-13)16(17,18)19)22-4-9-8(2-14(25)26)10(9)5-22/h3,7-11,24H,2,4-6H2,1H3,(H,25,26)/t7-,8?,9?,10?,11+/m0/s1 BUOGLNHQFZVQEU-IGDWCOGCSA-N 494902 US10988463, Example 32::[(1R,5S,6R)-3-{6-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]-2-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 1760 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494902&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773177 447113361 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029995 C[C@H]1[C@H](O)CN1c1nc(c(C)c(n1)C12CNCC1C2CC(O)=O)C(C)(F)F InChI=1S/C18H24F2N4O3/c1-8-14(17(3,19)20)22-16(24-6-12(25)9(24)2)23-15(8)18-7-21-5-11(18)10(18)4-13(26)27/h9-12,21,25H,4-7H2,1-3H3,(H,26,27)/t9-,10?,11?,12+,18?/m0/s1 MJXBCTNJZJRQQN-UHMFMTGSSA-N 494903 US10988463, Example 33::[(1R,5S,6R)-3-{6-(1,1-difluoroethyl)-2-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]-5-methylpyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 114 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494903&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 156905954 447113362 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029996 C[C@H]1[C@H](O)CN1c1cc(cc(n1)C(C)(F)F)N1CC2C(CC(O)=O)C2C1 InChI=1S/C18H23F2N3O3/c1-9-14(24)8-23(9)16-4-10(3-15(21-16)18(2,19)20)22-6-12-11(5-17(25)26)13(12)7-22/h3-4,9,11-14,24H,5-8H2,1-2H3,(H,25,26)/t9-,11?,12?,13?,14+/m0/s1 GCBUDLRCMDXYNG-YMBAYNEOSA-N 494904 US10988463, Example 34::[(1R,5S,6R)-3-{2-(1,1-difluoroethyl)-6-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]pyridin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 331 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494904&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773179 447113363 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029997 C[C@H]1C[C@H](O)CN1c1nc(c(Cl)c(n1)C12CNCC1C2CC(O)=O)C(F)(F)F InChI=1S/C17H20ClF3N4O3/c1-7-2-8(26)5-25(7)15-23-13(12(18)14(24-15)17(19,20)21)16-6-22-4-10(16)9(16)3-11(27)28/h7-10,22,26H,2-6H2,1H3,(H,27,28)/t7-,8-,9?,10?,16?/m0/s1 KGFXWQQFSSXHCM-WMWFRGFBSA-N 494905 US10988463, Example 35::[(1R,5S,6R)-3-{5-chloro-2-[(2S,4S)-4-hydroxy-2-methylpyrrolidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 188 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494905&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 156905955 447113364 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029998 C[C@@H]1N(C[C@@]1(C)O)c1nc(C(F)F)c(Cl)c(n1)N1CC2C(CC(O)=O)C2C1 InChI=1S/C17H21ClF2N4O3/c1-7-17(2,27)6-24(7)16-21-13(14(19)20)12(18)15(22-16)23-4-9-8(3-11(25)26)10(9)5-23/h7-10,14,27H,3-6H2,1-2H3,(H,25,26)/t7-,8?,9?,10?,17+/m0/s1 DXMVNXCELGRYED-XRZSBZPRSA-N 494906 US10988463, Example 36::[(1R,5S,6R)-3-{5-chloro-6-(difluoromethyl)-2-[(2S,3R)-3-hydroxy-2,3-dimethylazetidin-1-yl]pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 103 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494906 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494906&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773161 447113365 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1029999 OC(=O)CC1C2CN(CC12)c1cc(C(F)F)c(C#N)c(n1)N1CCCC1 InChI=1S/C18H20F2N4O2/c19-17(20)11-5-15(22-18(12(11)7-21)23-3-1-2-4-23)24-8-13-10(6-16(25)26)14(13)9-24/h5,10,13-14,17H,1-4,6,8-9H2,(H,25,26) XWDAMMRNAUVXCX-UHFFFAOYSA-N 494907 US10988463, Example 37::{(1R,5S,6s)-3-[5-cyano-4-(difluoromethyl)-6-(pyrrolidin-1-yl)Pyridin-2-yl]-3-azabicyclo[3.1.0]hex-6-yl}acetic acid Ketohexokinase Human 58.3 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494907&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773192 447113366 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030000 CC1CCCN1c1nc(cc(C(F)F)c1C#N)N1CC2C(CC(O)=O)C2C1 InChI=1S/C19H22F2N4O2/c1-10-3-2-4-25(10)19-13(7-22)12(18(20)21)5-16(23-19)24-8-14-11(6-17(26)27)15(14)9-24/h5,10-11,14-15,18H,2-4,6,8-9H2,1H3,(H,26,27) FSANLYQNVQEQAR-UHFFFAOYSA-N 494908 US10988463, Example 38::{(1R,5S,6s)-3-[5-cyano-4-(difluoromethyl)-6-(2-methylpyrrolidin-1-yl)pyridin-2-yl]-3-azabicyclo[3.1.0]hex-6-yl}acetic acid Ketohexokinase Human 25.3 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494908&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773187 447113367 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030001 CC1CCCCN1c1nc(cc(n1)C(F)(F)F)N1CC2C(CC(O)=O)C2C1 InChI=1S/C18H23F3N4O2/c1-10-4-2-3-5-25(10)17-22-14(18(19,20)21)7-15(23-17)24-8-12-11(6-16(26)27)13(12)9-24/h7,10-13H,2-6,8-9H2,1H3,(H,26,27) KZPFYVDBEFGFCK-UHFFFAOYSA-N 494909 US10988463, Example 39::{(1R,5S,6s)-3-[2-(2-methylpiperidin-1-yl)-6-(trifluoromethyl)pyrimidin-4-yl]-3-azabicyclo[3.1.0]hex-6-yl}acetic acid Ketohexokinase Human 24.8 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494909&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773166 447113368 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030002 C[C@H]1CCN1c1nc(C(F)F)c(Cl)c(n1)N1CC2C(CC(O)=O)C2C1 InChI=1S/C16H19ClF2N4O2/c1-7-2-3-23(7)16-20-13(14(18)19)12(17)15(21-16)22-5-9-8(4-11(24)25)10(9)6-22/h7-10,14H,2-6H2,1H3,(H,24,25)/t7-,8?,9?,10?/m0/s1 AFUXAZPXNHXKOK-KJTVYLTBSA-N 494881 US10988463, Example 40::[(1R,5S,6R)-3-{5-chloro-6-(difluoromethyl)-2-[(2S)-2-methylazetidin-1-yl]pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 11.1 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494881&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773157 447113340 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030003 CCc1c(nc(nc1N1CC2C(CC(O)=O)C2C1)N1C[C@@H](O)[C@@H]1C)C(F)F InChI=1S/C18H24F2N4O3/c1-3-9-15(16(19)20)21-18(24-7-13(25)8(24)2)22-17(9)23-5-11-10(4-14(26)27)12(11)6-23/h8,10-13,16,25H,3-7H2,1-2H3,(H,26,27)/t8-,10?,11?,12?,13+/m0/s1 FMNISGMWXYXRLZ-HCBLXQITSA-N 494910 US10988463, Example 41::[(1R,5S,6R)-3-{6-(difluoromethyl)-5-ethyl-2-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 111 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494910&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773173 447113369 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030004 C[C@H]1CCN1c1nc(N2CC3C(CC(O)=O)C3C2)c(C)c(n1)C(F)(F)F InChI=1S/C17H21F3N4O2/c1-8-3-4-24(8)16-21-14(17(18,19)20)9(2)15(22-16)23-6-11-10(5-13(25)26)12(11)7-23/h8,10-12H,3-7H2,1-2H3,(H,25,26)/t8-,10?,11?,12?/m0/s1 CIHZZUDENLLBPT-QHMVTXTQSA-N 494882 US10988463, Example 42::[(1R,5S,6R)-3-{5-methyl-2-[(2S)-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 8.80 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494882&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773158 447113341 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030005 C[C@H]1CCN1c1nc(C(F)F)c(C)c(n1)N1CC2C(CC(O)=O)C2C1 InChI=1S/C17H22F2N4O2/c1-8-3-4-23(8)17-20-14(15(18)19)9(2)16(21-17)22-6-11-10(5-13(24)25)12(11)7-22/h8,10-12,15H,3-7H2,1-2H3,(H,24,25)/t8-,10?,11?,12?/m0/s1 LVJUPDGITGVFAM-QHMVTXTQSA-N 494883 US10988463, Example 43::[(1R,5S,6R)-3-{6-(difluoromethyl)-5-methyl-2-[(2S)-2-methylazetidin-1-yl]pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 17.8 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494883&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773188 447113342 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030006 C[C@H]1CCN1c1nc(N2CC3C(CC(O)=O)C3C2)c(C)c(n1)C(C)(F)F InChI=1S/C18H24F2N4O2/c1-9-4-5-24(9)17-21-15(18(3,19)20)10(2)16(22-17)23-7-12-11(6-14(25)26)13(12)8-23/h9,11-13H,4-8H2,1-3H3,(H,25,26)/t9-,11?,12?,13?/m0/s1 SAZZPQRJVMUMRX-KODGCSJUSA-N 494911 US10988463, Example 44::[(1R,5S,6R)-3-{6-(1,1-difluoroethyl)-5-methyl-2-[(2S)-2-methylazetidin-1-yl]pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 51.4 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494911&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773191 447113370 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030007 C[C@H]1[C@H](O)CN1c1nc(C(F)F)c(C2CC2)c(n1)N1CC2C(CC(O)=O)C2C1 InChI=1S/C19H24F2N4O3/c1-8-13(26)7-25(8)19-22-16(17(20)21)15(9-2-3-9)18(23-19)24-5-11-10(4-14(27)28)12(11)6-24/h8-13,17,26H,2-7H2,1H3,(H,27,28)/t8-,10?,11?,12?,13+/m0/s1 SPINDYGKANBQAD-HCBLXQITSA-N 494912 US10988463, Example 45::[(1R,5S,6R)-3-{5-cyclopropyl-6-(difluoromethyl)-2-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 238 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494912 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494912&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773193 447113371 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030008 OC(=O)CC1C2CN(CC12)c1cc(c(C#N)c(n1)N1CCC1)C(F)(F)F InChI=1S/C17H17F3N4O2/c18-17(19,20)13-5-14(22-16(10(13)6-21)23-2-1-3-23)24-7-11-9(4-15(25)26)12(11)8-24/h5,9,11-12H,1-4,7-8H2,(H,25,26) NXOLFKWJZGICIS-UHFFFAOYSA-N 494913 US10988463, Example 46::{(1R,5S,6s)-3-[6-(azetidin-1-yl)-5-cyano-4-(trifluoromethyl)pyridin-2-yl]-3-azabicyclo[3.1.0]hex-6-yl}acetic acid Ketohexokinase Human 21.5 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494913 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494913&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773169 447113372 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030009 OC(=O)CC1C2CN(CC12)c1cc(nc(n1)N1CCC1)C(F)(F)F InChI=1S/C15H17F3N4O2/c16-15(17,18)11-5-12(20-14(19-11)21-2-1-3-21)22-6-9-8(4-13(23)24)10(9)7-22/h5,8-10H,1-4,6-7H2,(H,23,24) RUGKPNKATRBZGT-UHFFFAOYSA-N 494914 US10988463, Example 47::{(1R,5S,6s)-3-[2-(azetidin-1-yl)-6-(trifluoromethyl)pyrimidin-4-yl]-3-azabicyclo[3.1.0]hex-6-yl}acetic acid Ketohexokinase Human 619 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494914&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773171 447113373 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030010 C[C@@H]1N(C[C@@]1(C)O)c1nc(N2CC3C(CS(C)(=O)=O)C3C2)c(Cl)c(n1)C(F)(F)F InChI=1S/C17H22ClF3N4O3S/c1-8-16(2,26)7-25(8)15-22-13(17(19,20)21)12(18)14(23-15)24-4-9-10(5-24)11(9)6-29(3,27)28/h8-11,26H,4-7H2,1-3H3/t8-,9?,10?,11?,16+/m0/s1 ZXRQJLRKHRHUOY-PDGIKCBQSA-N 494915 (2S,3R)-1-[5-chloro-4-{(1R,5S,6S)-6-[(methylsulfonyl)methyl]-3-azabicyclo[3.1.0]hex-3-yl}-6-(trifluoromethyl)pyrimidin-2-yl]-2,3-dimethylazetidin-3-ol::US10988463, Example 48 Ketohexokinase Human 1359 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494915&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773189 447113374 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030011 C[C@H]1CCN1c1nc(cc(n1)C(F)(F)F)N1CC2C(CC(O)=O)C2C1 InChI=1S/C16H19F3N4O2/c1-8-2-3-23(8)15-20-12(16(17,18)19)5-13(21-15)22-6-10-9(4-14(24)25)11(10)7-22/h5,8-11H,2-4,6-7H2,1H3,(H,24,25)/t8-,9?,10?,11?/m0/s1 MDUYWDNWFXSMJJ-FBAUCUACSA-N 494916 US10988463, Example 49::[(1R,5S,6S)-3-{2-[(2S)-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 2084 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494916 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494916&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 140794817 447113375 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030012 C[C@H]1[C@H](O)CN1c1nc(N2CC3C(CC(O)=O)C3C2)c(F)c(c1C#N)C(C)(F)F InChI=1S/C19H21F3N4O3/c1-8-13(27)7-26(8)17-10(4-23)15(19(2,21)22)16(20)18(24-17)25-5-11-9(3-14(28)29)12(11)6-25/h8-9,11-13,27H,3,5-7H2,1-2H3,(H,28,29)/t8-,9?,11?,12?,13+/m0/s1 MAIIPHAMPGZLMT-VALCMSPSSA-N 494884 US10988463, Example 50::[(1R,5S,6R)-3-{5-cyano-4-(1,1-difluoroethyl)-3-fluoro-6-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]pyridin-2-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 4.40 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494884&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 140794830 447113343 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030013 OC(=O)CC1C2CN(CC12)c1cc(C(F)F)c(C#N)c(NC2CCC2)n1 InChI=1S/C18H20F2N4O2/c19-17(20)11-4-15(23-18(12(11)6-21)22-9-2-1-3-9)24-7-13-10(5-16(25)26)14(13)8-24/h4,9-10,13-14,17H,1-3,5,7-8H2,(H,22,23)(H,25,26) BSKAODOQCWFTKW-UHFFFAOYSA-N 494917 US10988463, Example 51::{(1R,5S,6s)-3-[5-cyano-6-(cyclobutylamino)-4-(difluoromethyl)pyridin-2-yl]-3-azabicyclo[3.1.0]hex-6-yl}acetic acid Ketohexokinase Human 150 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494917 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494917&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773163 447113376 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030014 C[C@H]1[C@H](O)CN1c1nc(cc(c1C#N)C(F)(F)F)N1CC2C(CCC(O)=O)C2C1 InChI=1S/C19H21F3N4O3/c1-9-15(27)8-26(9)18-11(5-23)14(19(20,21)22)4-16(24-18)25-6-12-10(13(12)7-25)2-3-17(28)29/h4,9-10,12-13,15,27H,2-3,6-8H2,1H3,(H,28,29)/t9-,10?,12?,13?,15+/m0/s1 OLIWZHXICYTNRA-PDQLHFSLSA-N 494918 3-[(1R,5S,6R)-3-{5-cyano-6-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]-4-(trifluoromethyl)pyridin-2-yl}-3-azabicyclo[3.1.0]hex-6-yl]propanoic acid::US10988463, Example 52 Ketohexokinase Human 82.5 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494918&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773174 447113377 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030015 C[C@H]1[C@H](O)CN1c1nc(N2CC3C(CC(O)=O)C3C2)c(C#N)c(n1)C(F)(F)F InChI=1S/C17H18F3N5O3/c1-7-12(26)6-25(7)16-22-14(17(18,19)20)9(3-21)15(23-16)24-4-10-8(2-13(27)28)11(10)5-24/h7-8,10-12,26H,2,4-6H2,1H3,(H,27,28)/t7-,8?,10?,11?,12+/m0/s1 HZOIXSCMIOVERO-CFQHMFBZSA-N 494919 US10988463, Example 53::[(1R,5S,6R)-3-{5-cyano-2-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 21.0 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494919 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494919&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773176 447113378 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030016 C[C@H]1[C@H](O)CN1c1nc(nc(c1C#N)C(F)(F)F)N1CC2C(CC(O)=O)C2C1 InChI=1S/C17H18F3N5O3/c1-7-12(26)6-25(7)15-9(3-21)14(17(18,19)20)22-16(23-15)24-4-10-8(2-13(27)28)11(10)5-24/h7-8,10-12,26H,2,4-6H2,1H3,(H,27,28)/t7-,8?,10?,11?,12+/m0/s1 MHWSTWPEVGHLEW-CFQHMFBZSA-N 494920 US10988463, Example 54::[(1R,5S,6R)-3-{5-cyano-4-[(2S,3R)-3-hydroxy-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-2-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 19.0 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494920 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494920&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773168 447113379 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1 1030017 C[C@@H]1N(C[C@@]1(C)O)c1nc(cc(C(F)F)c1C#N)N1CC2C(CC(O)=O)C2C1 InChI=1S/C19H22F2N4O3/c1-9-19(2,28)8-25(9)18-12(5-22)11(17(20)21)3-15(23-18)24-6-13-10(4-16(26)27)14(13)7-24/h3,9-10,13-14,17,28H,4,6-8H2,1-2H3,(H,26,27)/t9-,10?,13?,14?,19+/m0/s1 JDKXHSKHPARJRB-CGHHAMNPSA-N 494921 US10988463, Example 55::[(1R,5S,6R)-3-{5-cyano-4-(difluoromethyl)-6-[(2S,3R)-3-hydroxy-2,3-dimethylazetidin-1-yl]pyridin-2-yl}-3-azabicyclo[3.1.0]hex-6-yl]acetic acid Ketohexokinase Human 13.7 US Patent 10.7270/Q2SJ1PRS aid1805503 US10988463 Dowling, M; Fernando, D; Futatsugi, K; Huard, K; Magee, TV; Raymer, B; Shavnya, A; Smith, A; Thuma, B; Tsai, A; Tu, M 4/27/2021 11/1/2021 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=494921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=916&target=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=494921&enzyme=Ketohexokinase&column=ki&startPg=0&Increment=50&submit=Search 142773186 447113380 1 MEEKQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV 3B3L,3NBV,3NBW,3NC2,3NC9,3NCA,3Q92,3QA2,3QAI,3RO4,5WBM,5WBO,5WBP,5WBQ,5WBR,5WBZ,6UL7,6W0N,6W0W,6W0X,6W0Y,6W0Z Ketohexokinase KHK_HUMAN P50053 Q6IBK2 Q99532 Q9BRJ3 Q9UMN1